| 摘要 |
FIELD: chemistry.SUBSTANCE: present invention refers to immunology. There are presented versions of a human thymic stromal lymphopoietin (hTSLP) receptor antibodies characterised by the presence of variable reionso of a heavy and light chain or 3 CDR of a light chain and 3 CDR of a heavy chain respectively. There are described versions of a recovered or recombinant coding polynucleotide, a recovered host cell for producing the antibody containing coding DNAs. There is also described a method of treating an hTSLP-mediated inflammatory disorder involving the administration of a pharmaceutical composition containing an effective amount of the antibody.EFFECT: using the invention provides the new hTSLP antibodies that can find application in medicine for treating the inflammatory diseases associated with hTSLP activity.27 cl, 08 dwg, 2 tbl, 3 ex |
